Matinas Biopharma Holdingsincis A Clinical Stage Biopharmaceutical Company Based In Bedminsternew Jerseyfounded In 2013The Company Specializes In Advanced Drug Delivery Systemsfocusing On Therapies For Rare And Serious Infectious Diseasescardiovascular Disordersand Bacterial Infections Using Its Proprietary Lipid Nano Crystallncplatformthis Platform Allows For Safeintracellular Delivery Of Therapeutics Through Oral Administrationenhancing Drug Efficacy And Reducing Toxicity Matinas Has A Promising Product Pipeline That Includes Mat2203An Oral Antifungal In Phase 3 Trials For Various Fungal Infectionsand Mat2501An Oral Antibiotic Targeting Chronic Bacterial Infectionscurrently In Preclinical Developmentthe Company Is Also Working On Mat9001A Cardiovascular Lipid Therapystrategic Collaborations With Organizations Like Biontech Se And Genentech Aim To Expand The Applications Of The Lnc Platformwith A Dedicated Team Of 32 Employees And A Focus On Innovative Therapiesmatinas Is Positioned To Make Significant Contributions To The Biotechnology Sector
No conferences found for this company.
| Company Name | Matinas Biopharma Holdings Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
